BioHarvest Sciences Inc. (BHST)
(Delayed Data from NSDQ)
$7.55 USD
-0.13 (-1.63%)
Updated Aug 5, 2025 11:25 AM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BHST 7.55 -0.13(-1.63%)
Will BHST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BHST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHST
BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?
What Makes BioHarvest Sciences Inc. (BHST) a Good Fit for 'Trend Investing'
BHST: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Tops Revenue Estimates
BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for BHST
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. ...
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August ...
BioHarvest Sciences Schedules Annual General Meeting for June 2025
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
BioHarvest Sciences Expands with New Informed Sport-Certified VINIA® DailyChews 2X Formula